MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

11 Aug 2023 Evaluate
The turnover soared 57.43% to Rs. 29557.00 millions for the June 2023 quarter as compared to Rs. 18775.00 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 135.57% to Rs. 7809.00  millions from Rs. 3315.00 millions in the previous quarter.OP of the company witnessed a marginal growth to 12234.00 millions from 5960.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 29557.00 18775.00 57.43 29557.00 18775.00 57.43 87316.00 78369.00 11.42
Other Income 824.00 1551.00 -46.87 824.00 1551.00 -46.87 5484.00 1787.00 206.88
PBIDT 12234.00 5960.00 105.27 12234.00 5960.00 105.27 30028.00 20968.00 43.21
Interest 897.00 406.00 120.94 897.00 406.00 120.94 2782.00 1349.00 106.23
PBDT 11337.00 5554.00 104.12 11337.00 5554.00 104.12 25208.00 16426.00 53.46
Depreciation 1212.00 1231.00 -1.54 1212.00 1231.00 -1.54 4886.00 4787.00 2.07
PBT 10125.00 4323.00 134.21 10125.00 4323.00 134.21 20322.00 11639.00 74.60
TAX 2316.00 1008.00 129.76 2316.00 1008.00 129.76 5030.00 3060.00 64.38
Deferred Tax -48.00 -6.00 700.00 -48.00 -6.00 700.00 412.00 458.00 -10.04
PAT 7809.00 3315.00 135.57 7809.00 3315.00 135.57 15292.00 8579.00 78.25
Equity 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 41.39 31.74 30.39 41.39 31.74 30.39 34.39 26.76 28.53
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..